Abstract
Efficacy of centpropazine, a new antidepressant, has been evaluated in forty two patients of endogenous depression. The 4 week open trial was carried out in a dose-range of 40 to 120mg per day. A significant lowering of Hamilton Depression Rating Scale (HDRS) score was observed in 34 patient. The antidepressant effect could be detected in 9 patients within one week, in 28 cases in two weeks and in all the 34 patients by third week. Giddiness, headache, dryness of mouth and weakness were reported by 11 patients.
Full Text
The Full Text of this article is available as a PDF (138.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gupta P. P., Asthana O. P., Tangri A. N., Dhawan B. N. Clinical pharmacological studies on centpropazine--a new antidepressant compound. Indian J Med Res. 1989 Oct;90:360–362. [PubMed] [Google Scholar]
- Spitzer R. L., Endicott J., Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry. 1978 Jun;35(6):773–782. doi: 10.1001/archpsyc.1978.01770300115013. [DOI] [PubMed] [Google Scholar]